Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Ischemia

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Ischemia in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toppin, VA1
Harris, MB1
Kober, AM1
Leiter, JC1
St-John, WM1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Ischemia

ArticleYear
Persistence of eupnea and gasping following blockade of both serotonin type 1 and 2 receptors in the in situ juvenile rat preparation.
    Journal of applied physiology (Bethesda, Md. : 1985), 2007, Volume: 103, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Decerebrate State; Disease Models, Animal; Dose-Res

2007